Perma-Fix Environmental Services Expands PFAS Treatment Capabilities to New Waste Streams
Building on past successes, where the Perma-Fix process demonstrated the ability to destroy PFAS in high-concentration commercial waste, the next-generation treatment technology has been adapted to treat leachate and wastewater concentrate. In June, the Company received the first commercial batch of these new waste streams and will begin treatment imminently in the full-scale reactor, with plans to treat these materials in future units as well. The technology is designed with flexibility in mind, allowing for potential future deployment at customer sites. The current focus remains on centralized treatment at the Company's facilities.
The market for water separation technologies—including foam fractionation systems, reverse osmosis systems, and resin-based systems—is experiencing rapid growth as organizations seek to concentrate PFAS from large volumes of contaminated water. These separation technologies are highly complementary to the Company's destruction technology process. By collaborating with leading providers of these separation solutions, the Company delivers an efficient and cost-effective pathway for the final destruction of PFAS concentrate, addressing a critical gap in the remediation value chain and enabling customers to meet stringent regulatory standards while controlling costs.
The Perma-Fix system is competitively priced compared to alternative destruction methods. In addition to cost savings, this approach helps address the potential for legacy environmental liabilities that can arise from storage, incineration, or landfill disposal that do not provide for full destruction. By providing comprehensive destruction of PFAS compounds, the solution reduces customers' long-term liability exposure and supports compliance with evolving regulatory expectations—a benefit consistently recognized by clients and partners in past projects.
The PFAS remediation market continues to grow, driven by increasing regulatory scrutiny and the U.S Environmental Protection Agency's (EPA) ongoing consideration of hazardous waste classification for PFAS. Industry estimates suggest that the addressable market for PFAS treatment in the U.S. alone could reach several billion dollars annually, as tens of millions of gallons of contaminated water and soil require urgent remediation. The Company's scalable solution, combined with collaborations with companies specializing in water separation technologies, positions Perma-Fix to serve large generators of PFAS waste including municipalities, industrial clients, and government agencies—by providing a comprehensive approach from separation to final destruction.
Dr. Lou Centofanti, Executive Vice President of Perma-Fix, commented, 'We are excited to expand our PFAS treatment capabilities and address new waste streams, further strengthening our leadership in this critical sector. Our technology's proven performance in destroying PFAS , combined with our commitment to innovation, enables us to meet the growing needs of our customers and support a cleaner environment. By working closely with water separation technology providers—including foam fractionation, reverse osmosis, and resin systems—we are able to offer a comprehensive, efficient, and cost-effective solution for the destruction of PFAS concentrate. Importantly, our approach not only delivers cost savings but also minimizes the risk of future environmental liabilities for our clients by ensuring comprehensive, permanent destruction of these persistent chemicals.'
About Perma-Fix Environmental Services
Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the U.S Department of Energy (DOE), the U.S Department of Defense (DOD), and the commercial nuclear industry. The Company's nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities, nationwide.
Please visit us at http://www.perma-fix.com.
This press release contains 'forward-looking statements' which are based largely on the Company's expectations and are subject to various business risks and uncertainties, certain of which are beyond the Company's control. Forward-looking statements generally are identifiable by use of the words such as 'believe', 'expects', 'intends', 'anticipate', 'plan to', 'estimates', 'projects', and similar expressions. Forward-looking statements include, but are not limited to: treatment of leachate and wastewater concentrate in a full-scale reactor and in future units; deployment of PFAS technology at customer sites; reducing customers' long-term liability exposure and supports compliance with evolving regulatory expectations; and Company serving large generators of PFAS waste. While the Company believes the expectations reflected in this news release are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this release, including, without limitation, future economic conditions; industry conditions; competitive pressures; our ability to apply and market our new technologies; acceptance of our new technologies; the government or such other party to a contract granted to us fails to abide by or comply with the contract or to deliver waste as anticipated under the contract or terminates existing contracts; Congress fails to provides funding for the DOD's and DOE's remediation projects; inability to obtain new foreign and domestic remediation contracts; and the additional factors referred to under 'Risk Factors' and 'Special Note Regarding Forward-Looking Statements' of our 2024 Form 10-K and Form 10-Q for quarter ended March 31, 2025. The Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that bear upon forward-looking statements.
Contacts:David K. Waldman-US Investor RelationsCrescendo Communications, LLC
(212) 671-1021
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Sana Biotechnology Announces Pricing of Public Offering
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) ('Sana'), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public offering of 20,895,522 shares of its common stock at a price to the public of $3.35 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,492,537 shares of common stock at a price to the public of $3.3499 per pre-funded warrant, which represents the per share public offering price of each share of common stock less the $0.0001 per share exercise price for each pre-funded warrant. All of the shares and pre-funded warrants are to be sold by Sana. In addition, Sana has granted the underwriters a 30-day option to purchase up to an additional 3,358,208 shares of its common stock. The gross proceeds from the offering are expected to be approximately $75.0 million before deducting underwriting discounts and commissions and other offering expenses and excluding any exercise of the underwriters' option to purchase additional shares. The offering is expected to close on or about August 8, 2025, subject to satisfaction of customary closing conditions. Morgan Stanley, Goldman Sachs & Co. LLC, BofA Securities, and TD Cowen are acting as joint book-running managers for the offering. The offering is being made pursuant to a Registration Statement on Form S-3, including a base prospectus, previously filed with and declared effective by the SEC, and Sana has filed with the SEC a preliminary prospectus supplement and accompanying prospectus relating to the offering. A final prospectus supplement and accompanying prospectus relating to the offering will also be filed with the SEC. These documents can be accessed for free through the SEC's website at When available, copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email at prospectus@ Goldman Sachs & Co. LLC, Attn: Prospectus Department, at 200 West Street, New York, NY 10282, by telephone at (866) 471-2526 or by email at prospectus-ny@ BofA Securities, Attn: Prospectus Department, NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001 or by email at or TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017, by telephone at (855) 495-9846 or by email at This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful before registration or qualification under the securities laws of any such state or jurisdiction. About Sana Biotechnology Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana has operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA. Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements about Sana Biotechnology, Inc. (the 'Company,' 'we,' 'us,' or 'our') within the meaning of the federal securities laws, including those related to the timing of the closing of the offering and the expected gross proceeds. These forward-looking statements are neither promises nor guarantees and are subject to a variety of risks and uncertainties, including but not limited to: whether or not we will be able to raise capital through the sale of securities or consummate the offering; the final terms of the offering; the satisfaction of customary closing conditions; prevailing market conditions; general economic and market conditions as well as geopolitical developments; and other risks. Information regarding the foregoing and additional risks may be found in the section entitled 'Risk Factors' in documents that we file from time to time with the Securities and Exchange Commission, including the registration statement and the preliminary prospectus supplement relating to the public offering. These forward-looking statements are made as of the date of this press release, and we assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations & Media: Nicole in to access your portfolio
Yahoo
10 minutes ago
- Yahoo
Ziff Davis (NASDAQ:ZD) Surprises With Strong Q2, Stock Soars
Digital media company Ziff Davis (NASDAQ:ZD) reported revenue ahead of Wall Street's expectations in Q2 CY2025, with sales up 9.8% year on year to $352.2 million. The company's full-year revenue guidance of $1.47 billion at the midpoint came in 0.5% above analysts' estimates. Its non-GAAP profit of $1.24 per share was 4.5% above analysts' consensus estimates. Is now the time to buy Ziff Davis? Find out in our full research report. Ziff Davis (ZD) Q2 CY2025 Highlights: Revenue: $352.2 million vs analyst estimates of $337.1 million (9.8% year-on-year growth, 4.5% beat) Adjusted EPS: $1.24 vs analyst estimates of $1.19 (4.5% beat) Adjusted EBITDA: $107.7 million vs analyst estimates of $101.2 million (30.6% margin, 6.4% beat) The company reconfirmed its revenue guidance for the full year of $1.47 billion at the midpoint Management reiterated its full-year Adjusted EPS guidance of $6.96 at the midpoint EBITDA guidance for the full year is $523.5 million at the midpoint, above analyst estimates of $516.9 million Operating Margin: 9.5%, in line with the same quarter last year Free Cash Flow Margin: 7.6%, similar to the same quarter last year Market Capitalization: $1.30 billion 'We are very pleased with our second quarter results, which exceeded expectations and marked our strongest quarterly revenue growth since 2021,' said Vivek Shah, Chief Executive Officer of Ziff Davis. Company Overview Originally a pioneering technology publisher founded in 1927 that became famous for PC Magazine, Ziff Davis (NASDAQ:ZD) operates a portfolio of digital media brands and subscription services across technology, shopping, gaming, healthcare, and cybersecurity markets. Revenue Growth A company's long-term sales performance is one signal of its overall quality. Any business can have short-term success, but a top-tier one grows for years. With $1.45 billion in revenue over the past 12 months, Ziff Davis is a small player in the business services space, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and numerous distribution channels. As you can see below, Ziff Davis struggled to increase demand as its $1.45 billion of sales for the trailing 12 months was close to its revenue five years ago. This shows demand was soft, a poor baseline for our analysis. We at StockStory place the most emphasis on long-term growth, but within business services, a half-decade historical view may miss recent innovations or disruptive industry trends. Ziff Davis's annualized revenue growth of 2.7% over the last two years is above its five-year trend, but we were still disappointed by the results. This quarter, Ziff Davis reported year-on-year revenue growth of 9.8%, and its $352.2 million of revenue exceeded Wall Street's estimates by 4.5%. Looking ahead, sell-side analysts expect revenue to grow 2.1% over the next 12 months, similar to its two-year rate. This projection doesn't excite us and implies its newer products and services will not lead to better top-line performance yet. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Operating Margin Operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses – everything from the cost of goods sold to advertising and wages. It's also useful for comparing profitability across companies with different levels of debt and tax rates because it excludes interest and taxes. Ziff Davis has managed its cost base well over the last five years. It demonstrated solid profitability for a business services business, producing an average operating margin of 12%. Looking at the trend in its profitability, Ziff Davis's operating margin decreased by 5.9 percentage points over the last five years. Even though its historical margin was healthy, shareholders will want to see Ziff Davis become more profitable in the future. This quarter, Ziff Davis generated an operating margin profit margin of 9.5%, in line with the same quarter last year. This indicates the company's overall cost structure has been relatively stable. Earnings Per Share We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company's growth is profitable. Sadly for Ziff Davis, its EPS declined by 1.7% annually over the last five years while its revenue was flat. This tells us the company struggled because its fixed cost base made it difficult to adjust to choppy demand. Diving into the nuances of Ziff Davis's earnings can give us a better understanding of its performance. As we mentioned earlier, Ziff Davis's operating margin was flat this quarter but declined by 5.9 percentage points over the last five years. This was the most relevant factor (aside from the revenue impact) behind its lower earnings; interest expenses and taxes can also affect EPS but don't tell us as much about a company's fundamentals. Like with revenue, we analyze EPS over a more recent period because it can provide insight into an emerging theme or development for the business. For Ziff Davis, its two-year annual EPS growth of 3.1% was higher than its five-year trend. Accelerating earnings growth is almost always an encouraging data point. In Q2, Ziff Davis reported adjusted EPS at $1.24, up from $1.18 in the same quarter last year. This print beat analysts' estimates by 4.5%. Over the next 12 months, Wall Street expects Ziff Davis's full-year EPS of $6.60 to grow 3.8%. Key Takeaways from Ziff Davis's Q2 Results We enjoyed seeing Ziff Davis beat analysts' revenue expectations this quarter. We were also happy its full-year EPS guidance outperformed Wall Street's estimates. Overall, we think this was a solid quarter with some key areas of upside. The stock traded up 6.6% to $33.15 immediately following the results. Ziff Davis had an encouraging quarter, but one earnings result doesn't necessarily make the stock a buy. Let's see if this is a good investment. The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Sign in to access your portfolio
Yahoo
10 minutes ago
- Yahoo
NN (NASDAQ:NNBR) Misses Q2 Revenue Estimates
Industrial components supplier NN (NASDAQ:NNBR) missed Wall Street's revenue expectations in Q2 CY2025, with sales falling 12.3% year on year to $107.9 million. On the other hand, the company's outlook for the full year was close to analysts' estimates with revenue guided to $445 million at the midpoint. Its GAAP loss of $0.26 per share was 60% below analysts' consensus estimates. Is now the time to buy NN? Find out in our full research report. NN (NNBR) Q2 CY2025 Highlights: Revenue: $107.9 million vs analyst estimates of $110.8 million (12.3% year-on-year decline, 2.6% miss) EPS (GAAP): -$0.26 vs analyst expectations of -$0.16 (60% miss) Adjusted EBITDA: $13.18 million vs analyst estimates of $13.16 million (12.2% margin, in line) The company reconfirmed its revenue guidance for the full year of $445 million at the midpoint EBITDA guidance for the full year is $58 million at the midpoint, above analyst estimates of $53.41 million Operating Margin: -1.4%, in line with the same quarter last year Free Cash Flow was -$4.42 million compared to -$4.87 million in the same quarter last year Market Capitalization: $108 million Harold Bevis, President and Chief Executive Officer, said, 'NN delivered a solid quarter for gross margins, operating income, adjusted operating income, and adjusted EBITDA. We are pleased with our reported results, new business acquisition, and new business launches. We leveraged the soft market environment to upsize our business development activities and investments. Our soft top-line centers around certain automotive customers. Conversely, we have been able to partially offset this weakness through the contribution of new business launches and precious metals pass-through pricing.' Company Overview Formerly known as Nuturn, NN (NASDAQ:NNBR) provides metal components, bearings, and plastic and rubber components to the automotive, aerospace, medical, and industrial sectors. Revenue Growth A company's long-term performance is an indicator of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Unfortunately, NN struggled to consistently increase demand as its $433.7 million of sales for the trailing 12 months was close to its revenue five years ago. This wasn't a great result and is a sign of poor business quality. We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. NN's recent performance shows its demand remained suppressed as its revenue has declined by 6.6% annually over the last two years. This quarter, NN missed Wall Street's estimates and reported a rather uninspiring 12.3% year-on-year revenue decline, generating $107.9 million of revenue. Looking ahead, sell-side analysts expect revenue to grow 3.4% over the next 12 months. Although this projection suggests its newer products and services will fuel better top-line performance, it is still below the sector average. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Operating Margin Operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses – everything from the cost of goods sold to advertising and wages. It's also useful for comparing profitability across companies with different levels of debt and tax rates because it excludes interest and taxes. NN's high expenses have contributed to an average operating margin of negative 3.3% over the last five years. Unprofitable industrials companies require extra attention because they could get caught swimming naked when the tide goes out. It's hard to trust that the business can endure a full cycle. Analyzing the trend in its profitability, NN's operating margin decreased by 5.2 percentage points over the last five years. NN's performance was poor no matter how you look at it - it shows that costs were rising and it couldn't pass them onto its customers. NN's operating margin was negative 1.4% this quarter. The company's consistent lack of profits raise a flag. Earnings Per Share Revenue trends explain a company's historical growth, but the long-term change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Although NN's full-year earnings are still negative, it reduced its losses and improved its EPS by 30.6% annually over the last five years. The next few quarters will be critical for assessing its long-term profitability. Like with revenue, we analyze EPS over a more recent period because it can provide insight into an emerging theme or development for the business. For NN, EPS didn't budge over the last two years, a regression from its five-year trend. We hope it can revert to earnings growth in the coming years. In Q2, NN reported EPS at negative $0.26, down from negative $0.12 in the same quarter last year. This print missed analysts' estimates. Over the next 12 months, Wall Street expects NN to improve its earnings losses. Analysts forecast its full-year EPS of negative $1.13 will advance to negative $0.59. Key Takeaways from NN's Q2 Results We were impressed by NN's optimistic full-year EBITDA guidance, which blew past analysts' expectations. We were also glad its full-year revenue guidance was in line with Wall Street's estimates. On the other hand, its revenue missed and its EPS fell short of Wall Street's estimates. Overall, this quarter was mixed. The stock traded up 2.3% to $2.20 immediately after reporting. Is NN an attractive investment opportunity at the current price? If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
